Skip to main content
logo
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,900
0.00 (0.00%)
At close: Sep 18, 2026

HEM Pharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-20,873-23,842-7,646
Depreciation & Amortization
2,7462,5952,422
Loss (Gain) From Sale of Assets
790.357.02-
Asset Writedown & Restructuring Costs
534.93534.93-
Loss (Gain) From Sale of Investments
-17.46-30.47-24.89
Stock-Based Compensation
815.06929.21915.56
Provision & Write-off of Bad Debts
-239.950.14-
Other Operating Activities
2,7387,814418.39
Change in Accounts Receivable
652.692,708-2,568
Change in Inventory
-1,991-504.96-781.57
Change in Accounts Payable
453.18410.61549.43
Change in Other Net Operating Assets
6,9401,033-964.77
Operating Cash Flow
-7,423-8,345-7,680
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-11,233-9,755-4,687
Sale of Property, Plant & Equipment
77.9216.18-
Cash Acquisitions
-1,067-106.19-
Sale (Purchase) of Intangibles
-431.84-229.87-110.97
Investment in Securities
-1,1084,504-4,675
Other Investing Activities
-0-0-
Investing Cash Flow
-13,902-5,571-9,473

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Short-Term Debt Issued
-1,400-
Long-Term Debt Issued
-19,218-
Total Debt Issued
17,54120,618-
Long-Term Debt Repaid
--890.94-324.36
Net Debt Issued (Repaid)
16,60519,727-324.36
Issuance of Common Stock
1,6951,70716,512
Other Financing Activities
-4.8-8.06-915.47
Financing Cash Flow
18,37521,42515,272

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
114.121.313.91
Miscellaneous Cash Flow Adjustments
---0
Net Cash Flow
-2,8367,511-1,877

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-18,656-18,100-12,367
Free Cash Flow Growth
---
Free Cash Flow Margin
-115.57%-139.45%-82.08%
Free Cash Flow Per Share
-2614.97-2572.96-1945.77
Levered Free Cash Flow
-11,9374,409-
Unlevered Free Cash Flow
-11,0994,814-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Interest Paid
1,087418.68258.79
Cash Income Tax Paid
38.2220.7-22.47
Change in Working Capital
6,0553,647-3,765